Xuezhen ZENG

Intrahepatic cholangiocarcinoma (ICC) is an aggressive and heterogeneous malignancy derived from biliary tract in liver, with increasing incidence and mortality rates worldwide, dismal prognosis and limited treatment options. Novel effective therapeutic strategies are urgently needed…